Sanford Robertson Salesforce, Inc. (CRM) insider trading activity

Sanford Robertson is Director of Salesforce, Inc.. Currently has a direct ownership of 30,317 shares of CRM, which is worth approximately $7.11 Million. The most recent transaction as insider was on May 22, 2023, when has been sold 535 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.3K

0% 3M change

0% 12M change

Total Value Held $7.11 Million

SANFORD ROBERTSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2023	BUY Exercise of conversion of derivative security	-	535 Added 1.73%	30,317 Common Stock
Feb 22 2023	BUY Exercise of conversion of derivative security	-	535 Added 1.76%	29,782 Common Stock
Nov 22 2022	BUY Exercise of conversion of derivative security	-	425 Added 1.43%	29,247 Common Stock
Aug 22 2022	BUY Exercise of conversion of derivative security	-	425 Added 1.45%	28,822 Common Stock
Jun 30 2022	SELL Bona fide gift	-	11,000 Reduced 27.92%	28,397 Common Stock
May 22 2022	BUY Exercise of conversion of derivative security	-	425 Added 1.07%	39,397 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	-	426 Added 1.08%	38,972 Common Stock

Dec 17 2021	SELL Bona fide gift	-	11,000 Reduced 22.2%	38,546 Common Stock
Dec 17 2021	BUY Bona fide gift	-	11,000 Added 18.17%	49,546 Common Stock
Nov 22 2021	BUY Exercise of conversion of derivative security	-	410 Added 1.05%	38,546 Common Stock
Aug 22 2021	BUY Exercise of conversion of derivative security	-	410 Added 1.06%	38,136 Common Stock
May 22 2021	BUY Exercise of conversion of derivative security	-	410 Added 1.08%	37,726 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	411 Added 1.09%	37,316 Common Stock
Nov 22 2020	BUY Exercise of conversion of derivative security	-	514 Added 1.37%	36,905 Common Stock
Aug 31 2020	SELL Open market or private sale	$4,078,050 $271.87 p/Share	15,000 Reduced 29.19%	36,391 Common Stock
Aug 22 2020	BUY Exercise of conversion of derivative security	-	514 Added 0.99%	51,391 Common Stock
Jun 18 2020	SELL Open market or private sale	$4,639,750 $185.59 p/Share	25,000 Reduced 32.95%	50,877 Common Stock
May 22 2020	BUY Exercise of conversion of derivative security	-	514 Added 0.67%	75,877 Common Stock

Also insider at

SAVA

CASSAVA SCIENCES INC Healthcare

Director